Europe

f9a57bfe-51c7-11e9-8939-5623721d3707

Europe’s pragmatic approach to clinical evidence for legacy devices – or why the devil is always in the detail…

By Arthur Brandwood | 30 March, 2019
Regulatory affairs demand attention to detail. So when the European Medical Devices Coordination Group released document MDCG 2019-3 - Interpretation of Article 54(2)b we regulatory geeks just knew we should...
TrainXstation

Halfway there? Will the MDR/IVDR train arrive on time – and what about Brexit?

By Luis Jimenez | 3 December, 2018
As the implementation journey for the EU MDR/IVDR passes the halfway point, we provide an update to the current state of play and the impact on our industry. Many, if...

Search

Recent Posts

Harmonised Standards for MDR? CEN/CENELEC say “Non”

Jul 2, 2020

FAQs Regarding the Australian R&D Tax Incentive and Regulatory Services

Jul 1, 2020

Addendum to TGA Deadlines: Medicine Labelling Compliance and COVID-19

Jun 19, 2020

Proposed delayed commencement of certain Medical Device Regulatory Changes

Jun 12, 2020

Software as a Medical Device – Upcoming Changes to the Australian Regulations

May 29, 2020

Keeping it Clean: Regulation of Hand Sanitisers as Cosmetics or Therapeutic Goods

May 19, 2020

Categories

Categories

Archives

Archives

Archives

Tags

510(k) APAC Australia Biocompatibility Brexit CE CE Certificates clinical trials coronavirus COVID19 de novo distribution EU Europe FDA GHTF Harmonization IMDRF IVD IVDD IVDR MDD MDR MDSAP medical device Medical Device Regulations medical devices medicines MHRA New Zealand Notified Bodies PMA PMDA postmarket private health insurance QMS Quality Systems Reform regulatory Reimbursement SaMD Software standards TGA UDI